Human non-hodgkin lymphoma cured by novel nuclear medicine therapy in preclinical model Isra Zaman13 April 2023 9:00 AM ISTNon-Hodgkin lymphoma is a common blood malignancy. The American Cancer Society estimates that more than 80,500 new cases and 20,100 deaths will occur...
Nintedanib and prednisone taper combo improves pulmonary exacerbations in radiation pneumonitis Medha Baranwal12 April 2023 8:00 PM ISTUSA: Adding nintedanib to a prednisone taper improves pulmonary exacerbations in grade 2 or higher (G2+) radiation pneumonitis (RP) patients,...
Pembrolizumab effective as post-nephrectomy adjuvant therapy in clear cell renal cell carcinoma: LANCET Dr.Niharika Harsha B12 April 2023 9:30 AM ISTUpdated results from the KEYNOTE-564 trial showed that pembrolizumab monotherapy can be used as a standard of care for patients with renal...
PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients Jacinthlyn Sylvia12 April 2023 2:15 AM ISTResearchers have found in a new research that PET CT better than contrast-enhanced CT as survival predictor in metastatic breast cancer patients....
Novel immunotherapy agent safe, shows promise against high-risk prostate cancers Dr. Kamal Kant Kohli11 April 2023 8:00 PM ISTA new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against...
Protein with novel anti-tumoral activities identified Isra Zaman11 April 2023 9:30 AM ISTThe tumor suppressor gene called TP53 effectively restricts the development and growth of many different tumor types across the human body, and it is...
Cellular identity discovery has potential to impact cancer treatments: Study Isra Zaman11 April 2023 9:00 AM ISTA puzzle regarding PRC2 has intrigued the Bracken lab and other scientists in the field for years: two forms (PRC2.1 and PRC2.2) exist in the cell but...
Prostate cancer risk prediction algorithm could help target testing of men at greatest risk Dr. Kamal Kant Kohli10 April 2023 9:30 AM ISTCambridge scientists have created a comprehensive tool for predicting an individual's risk of developing prostate cancer, which they say could help...
Simple blood test can accurately predict neuroendocrine tumor response to radiopharmaceutical therapy Isra Zaman10 April 2023 9:00 AM ISTWhile biomarkers have been used to predict the outcomes of treatments for breast, prostate, and other cancers, there are currently no objective means...
Novel immunotherapy delivery approach benefits some melanoma patients with leptomeningeal disease Dr. Kamal Kant Kohli10 April 2023 2:00 AM ISTA novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous (IV) immunotherapy was safe and...
New immunotherapy agent safe and promising against high-risk prostate cancers Isra Zaman8 April 2023 9:15 AM ISTEnoblituzumab, a monoclonal antibody drug works by binding to a protein called B7-H3 that is overexpressed on prostate cancer cells and believed to...
SGLT2 inhibitors use lowers cancer risk in patients with diabetes Medha Baranwal7 April 2023 11:30 AM ISTTaiwan: Patients with diabetes who receive sodium-glucose cotransporter-2 (SGLT2) inhibitors are at a significantly lower risk of cancer, a new study...
